...series B round led by Symbiosis II LLC, with participation from new investors Solasta Ventures and Livzon Pharmaceutical Group...
...Partners Logos Capital Janus Henderson Investors Atlas Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group...

...biological engineering. CEO Robert Connelly told BioCentury that the series B, led by new investor Livzon Pharmaceutical Group...

...Calif. Business: Supply/Service, Diagnostic, Cancer Date completed: 2015-06-17 Type: Venture financing Raised: $25.5 million Investors: Livzon Pharmaceutical Group...

...and open clinical trials (see BioCentury, Feb. 16). Cynvenio Biosystems Inc. , Westlake Village, Calif. Livzon Pharmaceutical Group...

...Biosystems Inc. (Westlake Village, Calif.) raised $25.5 million in a series B round led by Livzon Pharmaceutical Group...

...and psoriasis (see BioCentury, Jan. 13 & Sept. 22). Livzon Mabpharm is a JV between Livzon Pharmaceutical Group...
...subsequently reverse-merged with Zalicus Inc. (see BioCentury, July 21). Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS), Boston, Mass. Livzon Pharmaceutical Group...

...close this summer. Epirus' B round was led by Livzon Mabpharm Inc., a JV between Livzon Pharmaceutical Group...